BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

518 related articles for article (PubMed ID: 7869662)

  • 1. Virulence determinants of uropathogenic Escherichia coli and Proteus mirabilis.
    Mobley HL; Island MD; Massad G
    Kidney Int Suppl; 1994 Nov; 47():S129-36. PubMed ID: 7869662
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mannose-resistant Proteus-like and P. mirabilis fimbriae have specific and additive roles in P. mirabilis urinary tract infections.
    Zunino P; Sosa V; Schlapp G; Allen AG; Preston A; Maskell DJ
    FEMS Immunol Med Microbiol; 2007 Oct; 51(1):125-33. PubMed ID: 17854474
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Decreased predominance of papG class II allele in Escherichia coli strains isolated from adults with acute pyelonephritis and urinary tract abnormalities.
    Tseng CC; Huang JJ; Ko WC; Yan JJ; Wu JJ
    J Urol; 2001 Nov; 166(5):1643-6. PubMed ID: 11586193
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Fimbriae of uropathogenic Proteus mirabilis.
    Rocha SP; Pelayo JS; Elias WP
    FEMS Immunol Med Microbiol; 2007 Oct; 51(1):1-7. PubMed ID: 17640292
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Proteus mirabilis genes that contribute to pathogenesis of urinary tract infection: identification of 25 signature-tagged mutants attenuated at least 100-fold.
    Burall LS; Harro JM; Li X; Lockatell CV; Himpsl SD; Hebel JR; Johnson DE; Mobley HL
    Infect Immun; 2004 May; 72(5):2922-38. PubMed ID: 15102805
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The prevalence of virulence genes of E. coli strains isolated from children with urinary tract infection.
    Farshad S; Emamghorashi F
    Saudi J Kidney Dis Transpl; 2009 Jul; 20(4):613-7. PubMed ID: 19587502
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Are quinolone-resistant uropathogenic Escherichia coli less virulent?
    Vila J; Simon K; Ruiz J; Horcajada JP; Velasco M; Barranco M; Moreno A; Mensa J
    J Infect Dis; 2002 Oct; 186(7):1039-42. PubMed ID: 12232848
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Characterisation of Escherichia coli strains associated with canine urinary tract infections.
    Westerlund B; Pere A; Korhonen TK; Jarvinen AK; Siitonen A; Williams PH
    Res Vet Sci; 1987 May; 42(3):404-6. PubMed ID: 2887017
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Construction of an MR/P fimbrial mutant of Proteus mirabilis: role in virulence in a mouse model of ascending urinary tract infection.
    Bahrani FK; Massad G; Lockatell CV; Johnson DE; Russell RG; Warren JW; Mobley HL
    Infect Immun; 1994 Aug; 62(8):3363-71. PubMed ID: 7913698
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [The role of E. coli adhesiveness in the pathogenesis and clinical course of urinary tract infections].
    Krzeska I; Ostojska J; Dzierzanowska D
    Pol Tyg Lek; 1992 Aug 7-17; 47(31-33):706-9. PubMed ID: 1362812
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Detection of virulence factors using DNA probes in uropathogenic strains of Escherichia coli].
    RodrĂ­guez-Alvarez E; Abalia I; Bilbao JR; Umaran A; Cisterna R
    Enferm Infecc Microbiol Clin; 1994 Feb; 12(2):66-70. PubMed ID: 7912109
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Aggregative adherence of uropathogenic Proteus mirabilis to cultured epithelial cells.
    Rocha SP; Elias WP; Cianciarullo AM; Menezes MA; Nara JM; Piazza RM; Silva MR; Moreira CG; Pelayo JS
    FEMS Immunol Med Microbiol; 2007 Nov; 51(2):319-26. PubMed ID: 17714491
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In vivo phase variation of MR/P fimbrial gene expression in Proteus mirabilis infecting the urinary tract.
    Zhao H; Li X; Johnson DE; Blomfield I; Mobley HL
    Mol Microbiol; 1997 Mar; 23(5):1009-19. PubMed ID: 9076737
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Molecular epidemiology of 3 putative virulence genes for Escherichia coli urinary tract infection-usp, iha, and iroN(E. coli).
    Bauer RJ; Zhang L; Foxman B; Siitonen A; Jantunen ME; Saxen H; Marrs CF
    J Infect Dis; 2002 May; 185(10):1521-4. PubMed ID: 11992291
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Distribution of uropathogenic virulence genes in Escherichia coli isolated from patients with urinary tract infection.
    Tarchouna M; Ferjani A; Ben-Selma W; Boukadida J
    Int J Infect Dis; 2013 Jun; 17(6):e450-3. PubMed ID: 23510539
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Uropathogenic Escherichia coli--ExPEC pathotype, the best characterized].
    Usein CR; Damian M
    Bacteriol Virusol Parazitol Epidemiol; 2003; 48(1):31-6. PubMed ID: 15214194
    [TBL] [Abstract][Full Text] [Related]  

  • 17. New aspects of the role of MR/P fimbriae in Proteus mirabilis urinary tract infection.
    Zunino P; Geymonat L; Allen AG; Preston A; Sosa V; Maskell DJ
    FEMS Immunol Med Microbiol; 2001 Aug; 31(2):113-20. PubMed ID: 11549418
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Relationship between O serotype and virulent genes in Escherichia coli causing urinary tract infections.
    Emamghoraishi F; Farshad S; Kalani M
    Iran J Kidney Dis; 2011 Jul; 5(4):234-7. PubMed ID: 21725179
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Relation between P-fimbriae and resistance to amoxicillin, carbenicillin and tetracycline in uropathogenic strains of Escherichia coli].
    Vranes J; Schönwald S; Zagar Z
    Lijec Vjesn; 1994; 116(7-8):178-81. PubMed ID: 7853994
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Repression of bacterial motility by a novel fimbrial gene product.
    Li X; Rasko DA; Lockatell CV; Johnson DE; Mobley HL
    EMBO J; 2001 Sep; 20(17):4854-62. PubMed ID: 11532949
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 26.